American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based joint venture between Asian conglomerates China Resources Group and Charoen Pokphand Group, according to a statement released on Saturday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?